ArticleMolecules (Basel, Switzerland)2026
Improving Mechanical Properties of Carboxyl-Terminated Polybutadiene (CTPB) Binder System Using a Cure Accelerator.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To address the issues of slow curing rate, post-curing reactions, and suboptimal mechanical properties in the carboxyl-terminated polybutadiene (CTPB)/epoxy resin (EP) binder system used for solid propellants, this study optimized the curing system by introducing 593 aliphatic amine compounds containing primary and secondary amine groups as a cure accelerator. It is found that the incorporation of the cure accelerator improved the fracture strength and elongation at break of the CTPB/EP binder system. With the addition of 0.3 wt.% cure accelerator, the tensile fracture strength increased to 0.37 MPa, while the elongation at break reached 655%. Moreover, augmenting the quantity of cure accelerator can substantially elevate the crosslink density and gel fraction of the binder system. When the addition reaches 0.3 wt.%, the crosslink density is 4.3 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.